SCHEMBL25850265

SCHEMBL25850265

c1ccc(-c2cc(-c3ccc4ccccc4c3)nc(-c3cccc(-c4cccc5oc6cc(-c7ccc(N(c8ccccc8)c8ccccc8-c8ccccc8)cc7)ccc6c45)c3)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.36
CYP1B1 Q16678 1/20 0.36
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
HCRTR1 O43613 1/20 0.31
GLA P06280 1/20 0.31
CYP1A2 P05177 1/20 0.31
CTRC Q99895 1/20 0.30
HSD17B1 P14061 1/20 0.30
HSD17B2 P37059 1/20 0.30
PIM1 P11309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420462 0.90 ALDH1A1 (0.34) KDM4EMEN1ALDH1A1MAPTKMT2A
SCHEMBL24255614 0.89 CYP1A1 (0.35) CYP1A1CYP1B1KDM4EMEN1ALDH1A1
SCHEMBL26778943 0.89 CYP1A1 (0.41) CYP1A1CYP1B1KDM4EMEN1ALDH1A1
SCHEMBL26420608 0.88 CYP1A1 (0.37) CYP1A1CYP1B1KDM4EMEN1ALDH1A1
SCHEMBL25978198 0.87 CYP1A1 (0.38) CYP1A1CYP1B1KDM4EMEN1ALDH1A1
SCHEMBL25978446 0.87 CYP1A1 (0.39) CYP1A1CYP1B1KDM4EMEN1ALDH1A1
SCHEMBL25975618 0.87 CYP1A1 (0.36) CYP1A1CYP1B1KDM4EMEN1ALDH1A1
SCHEMBL24841646 0.87 PLA2G2A (0.35) ALDH1A1MAPTHCRTR1HSD17B1HSD17B2
SCHEMBL24841414 0.87 PLA2G2A (0.35) ALDH1A1MAPTHCRTR1HSD17B1HSD17B2
SCHEMBL24777803 0.87 HSD17B1 (0.33) KDM4EMEN1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
EP-4206198-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT Materials Co., Ltd. (KR) 2023-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 CYP1A1 66/4885CYP1B1 194/4885KDM4E 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.